Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- 1 April 2018
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 33 (4), 581-598
- https://doi.org/10.1016/j.ccell.2018.03.005
Abstract
No abstract availableFunding Information
- Ludwig Institute for Cancer Research
- Parker Institute for Cancer Immunotherapy
- NIH (P30 CA008748)
This publication has 192 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- TOR in the immune systemCurrent Opinion in Cell Biology, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Enhancing CD8 T-cell memory by modulating fatty acid metabolismNature, 2009
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceOncogene, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007